AT-007 |
カタログ番号GC38584 |
AT-007 は、100 pM の IC50 値を持つガラクトース血症の治療のための経口活性中枢神経系 (CNS) 浸透剤アルドースレダクターゼ阻害剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170729-29-8
Sample solution is provided at 25 µL, 10mM.
AT-007 is an orally active central nervous system (CNS) penetrant Aldose Reductase inhibitor for treatment of Galactosemia with an IC50 value of 100 pM[1][2].
[1]. Maeve Conneighton, et al. Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia. [2]. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. APPLIED THERAPEUTICS, INC.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *